Inventor · disambiguated record
Simon Bedford
Also filed as: BEDFORD SIMON · BEDFORD SIMON TIMOTHY
13 granted patents·7 pending applications·16 citations·filing 2008–2024
88Inventor score
Top patents by PatentIndex Score
20 records- 0181US9675594B2Arylpyrrolopyridine derived compounds as LRRK2 inhibitorsH LUNDBECK AS·Filed 2016·Granted Jun 13, 2017·4 cites·12 claims
- 0276US8354415B2Thienopyrimidine compounds and compositionsVERNALIS R&D LTD·Filed 2008·Granted Jan 15, 2013·3 cites·26 claims
- 0375US10556911B2Thienopyrimidine compoundsVERNALIS R&D LTD·Filed 2018·Granted Feb 11, 2020·1 cites·36 claims
- 0475US9920066B2Thienopyrimidine compoundsVERNALIS R&D LTD·Filed 2017·Granted Mar 20, 2018·1 cites·8 claims
- 0574US9120807B2Thienopyrimidine compoundsJORDAN ALLAN·Filed 2008·Granted Sep 1, 2015·3 cites·25 claims
- 0671US9610290B2Thienopyrimidine compoundsVERNALIS R&D LTD·Filed 2015·Granted Apr 4, 2017·1 cites·24 claims
- 0768US9499542B2Arylpyrrolopyridine derived compounds as LRRK2 inhibitorsH LUNDBECK AS·Filed 2014·Granted Nov 22, 2016·1 cites·10 claims
- 0868US8916591B2Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activitySTOKES STEPHEN·Filed 2009·Granted Dec 23, 2014·2 cites·17 claims
- 0967US11028097B2Thienopyrimidine compoundsVERNALIS R&D LTD·Filed 2019·Granted Jun 8, 2021·0 cites·20 claims
- 1064US2025228865A1Compounds for enhancing read through of genes containing premature termination codons and methods for making and using the sameSANOFI US SERVICES INC·Filed 2024·Application pending·0 cites
- 1164US2020361905A1Indolyl-Pyridone Derivatives Having Checkpoint Kinase 1 Inhibitory ActivityVERNALIS R&D LTD·Filed 2020·Application pending·0 cites
- 1259US10696652B2Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activityVERNALIS R&D LTD·Filed 2018·Granted Jun 30, 2020·0 cites·16 claims
- 1359US9604975B2Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activityVERNALIS R&D LTD·Filed 2014·Granted Mar 28, 2017·0 cites·14 claims
- 1454US2017298043A1Indolyl-Pyridone Derivatives Having Checkpoint Kinase 1 Inhibitory ActivityVERNALIS R&D LTD·Filed 2017·Application pending·0 cites
- 1553US2014315901A1Arylpyrrolopyridine derived compounds as LRRK2 inhibitorsLUNDBECK & CO AS H·Filed 2014·Application pending·0 cites
- 1652US9765056B2Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing themSERVIER LAB·Filed 2014·Granted Sep 19, 2017·0 cites·15 claims
- 1752US2024150293A1Spirocyclohexane derivatives, pharmaceutical compositions containing them and their uses as anti-apoptotic inhibitorsSERVIER LAB·Filed 2022·Application pending·0 cites
- 1848US2010305143A1Pyrrolopyrimidine compoundsVERNALIS R&D LTD·Filed 2008·Application pending·0 cites
- 1947US10662173B2Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing themSERVIER LAB·Filed 2017·Granted May 26, 2020·0 cites·17 claims
- 2043US2022289734A13,6-diamino-pyridazin-3-yl derivatives, pharmaceutical compositions containing them and their uses as pro-apoptotic agentsSERVIER LAB·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Simon Bedford files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →